Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04623476
Status:
UNKNOWN
Last Update Posted:
2020-12-28
First Post:
2020-10-29
Brief Title:
PAtophysiological Nodal-based Approach for Crohns Disease Excision
Sponsor:
University of Rome Tor Vergata
Organization:
University of Rome Tor Vergata
Study Overview
Official Title:
PAtophysiological Nodal-based Approach for Crohns Disease Excision A PILOT Study
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PANACEAPILOT
Brief Summary:
Single centre prospective pilot study on surgery for Crohns disease CD CD universally recurs after surgery and no technique so far has been proven to reduce recurrence
The investigators speculate that a different surgical technique based on pathophysiology of the disease may prove successful in reducing rates of recurrence
Consecutive CD patients with a surgical indication for ileocolic disease will receive an extended procedure including a lymphadenectomy Pathophysiologic excision for Crohns disease
Primary outcome will be endoscopic recurrence rates at 6 and 12 months from surgery
The investigators speculate that a different surgical technique based on pathophysiology of the disease may prove successful in reducing rates of recurrence
Consecutive CD patients with a surgical indication for ileocolic disease will receive an extended procedure including a lymphadenectomy Pathophysiologic excision for Crohns disease
Primary outcome will be endoscopic recurrence rates at 6 and 12 months from surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None